ArticleAmerican journal of hematology2022
A comment on: "Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo-controlled randomized cross-over clinical trial".
Wenke Moris et al.PubMed ↗Publisher ↗
No numbers read from the abstract.